-
Elon Musk Shares Major Update On Neuralink Technology Designed To Help Blind People See

Elon Musk has made a striking claim about a technology that could change the future of vision restoration. Neuralink’s experimental brain implant, Blindsight, is reportedly ready from an engineering standpoint and awaiting regulatory approval before moving towards human testing. The technology has an ambitious goal: helping people with severe vision loss experience visual perception by…
-
Scientists Find a Way to Stop Childhood Cavities Without Drilling

For young children with cavities, a routine trip to the dentist can sometimes lead to a frightening experience involving drills, injections and, in severe cases, surgery under general anesthesia. Now, a major U.S. clinical trial suggests that a simple liquid applied directly to decayed teeth could help many children avoid those procedures. The treatment, known…
-
Why Tyson Foods, One of America’s Largest Meat Companies, Backs Lab-Grown Meat

There is a version of this story that sounds like a mistake. One of the biggest names in American chicken, a company whose brand is practically a synonym for the drumstick, has spent years quietly funneling money into technology designed to produce meat without raising or killing a single animal. It is not a mistake,…
-
FDA Approves First Non-Addictive Painkiller That Actually Works

Facing a serious injury or surgery often brings a difficult choice: suffer through the pain or accept a prescription that carries the terrifying risk of addiction. That fear has left countless people searching for a safer middle ground, and finally, there is an answer. A newly approved treatment is promising to silence pain without touching…
-
Sickle Cell Anemia Cure Reported in New York, a Major Medical First

For decades, sickle cell disease has meant living under the constant threat of pain crises that can strike without warning and derail school, work, and everyday plans. Now, doctors in New York are describing a turning point: a young adult treated with a one-time gene therapy has remained free of sickle cell symptoms, raising the…

